An evaluation of the abuse potential of modafinil using methylphenidate as a reference

Journal of Psychopharmacology

Volumn 14, Issue 1, 2000, Pages 53-60

  Jasinski, Donald R ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Abuse liability; Human subjects; Methylphenidate; Modafinil; Narcolepsy; Subjective effects

Indexed keywords

COCAINE; METHYLPHENIDATE; MODAFINIL;

ADULT; ARTICLE; BEHAVIOR; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG DISCRIMINATION; DRUG MECHANISM; HUMAN; HUMAN EXPERIMENT; MALE; PHARMACODYNAMICS; PHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SLEEP PATTERN; TACHYCARDIA;

EID: 0034061801     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110001400107     Document Type: Article

References (21)

1. Akoaka H, Roussel B, Lin J-S, Chouvet G, Jouvet M (1991) Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity. Neurosci Lett 123: 20-22
2. Andrews H P, Snee R D, Sarner M N (1980) Graphical display of means. Am Statist 34: 195-199
3. Chait L D, Uhlenhuth E H, Johanson C E (1987) Reinforcing and subjective effects of several anoretics in normal human volunteers. J Pharmacol Exp Ther 242: 777-783
4. Chait L D, Uhlenhuth E H, Johanson C E (1988) Phenylpropanolamine: reinforcing and subjective effects in normal volunteers. Psychopharmacology 96: 212-217
5. Cochran W G, Cox G M (1957) Experimental designs, 2nd edn. John Wiley and Sons, New York
6. DeSereville J S, Boer C, Rambert F A, Duteil J (1994) Lack of presynaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vitro voltammetry studies. Neuropharmacology 33: 755-761
7. Duteil J, Rambert F A, Pessonnier J, Hermant J-F, Gombert R (1990) Central alphal-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil: studies with experimental animals. Eur J Pharmacol 180: 49-58
8. Finney D J (1964) Statistical method in biological assay, 2nd edn. Charles Griffen & Company Limited, London, pp. 99-136
9. Guilleminault C (1994) Narcolepsy syndrome. In Kryger M H, Roth T, Dement W C (eds). Principles and practice of sleep medicine, 2nd edn. Saunders, Philadelphia, pp. 549-561
10. Jasinski D R (1977) Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In Martin W R (ed.), Handbook of experimental pharmacology, vol. 45/1. Drug addiction I. Springer-Verlag, Heidelberg, pp. 197-258
11. Jasinski D R, Henningfield J E (1989) Human abuse liability assessment by measurement of subjective and physiologic effects. In Fischman M W, Mello N K (eds), Testing for abuse liability of drugs in humans. NIDA research monograph no. 92. National Institute on Drug Abuse, Rockville, MD, pp. 73-100
12. Lin J S, Roussel B, Akoaka H, Fort P, Debily G, Jouvet M (1992) Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591: 319-329
13. Lin J S, Hou Y, Jouvet M (1996) Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 96: 14128-14133
14. Martin W R, Sloan J S, Sapira B D, Jasinski D R (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12: 245-258
15. Mignot E, Nishino S, Guilleminault C, Dement W C (1994) Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17: 436-437
16. Mitler M M, Aldrich M S, Koob G F, Zarcone V P (1994) Narcolepsy and its treatment with stimulants. ASDA standards of practice. Sleep 17: 342-371
17. Parran T V Jr, Jasinski D R (1991) Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch Intern Med 151: 781-783
18. Simon P, Panissaud C, Costentin J (1994) The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. Psychopharmacology 114: 597-600
19. Simon P, Hemet C, Ramassamy C, Constentin J (1995) Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 5: 509-514
20. Warot D, Corruble E, Payan C, Weil J S, Peuch A J (1993) Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur Psychiatry 8: 201-208
21. Wong Y N, Simcoe D, Hartman L N, Laughton W B, King S P, McCormick C G, Grebow P E (1999) A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30-40